← Scroll for more →
Financial Statements — RLNDF
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Cash & Equivalents | -- | 0.08 | -- |
| Total Current Assets | 0.24 | 0.09 | 0.38 |
| Total Non-current Assets* | 0.00 | 0.00 | 0.00 |
| Total Assets | 0.24 | 0.09 | 0.38 |
| Total Current Liabilities | 0.56 | 0.69 | 0.39 |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 0.56 | 0.69 | 0.39 |
| Retained Earnings | (2.86) | (2.69) | (2.09) |
| Total Stockholder Equity | (0.32) | (0.60) | (0.01) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in thousands USD) (except per-share rows)| Metric | Q2 2025 |
|---|---|
| Research & Development | 277.36 |
| Total Operating Expenses | 599.38 |
| Operating Income | (599.38) |
| Pretax Income | (599.38) |
| Net Income | (599.38) |
| Basic EPS | (0.04) |
| Diluted EPS | (0.04) |
← Scroll for more columns →
Cash Flow Statement
(in thousands USD)| Metric | Q2 2025 |
|---|---|
| Operating Cash Flow | (274.57) |
| Financing Cash Flow | 89.80 |
← Scroll for more columns →